Prostate probe with SPECT technique

Slides:



Advertisements
Similar presentations
Instruments for Radiation Detection and Measurement Lab # 4.
Advertisements

F. Garibaldi – INFN Roma and ISS
Imaging Molecolare con radionuclidi: un potente mezzo di indagine di processi biologici in vivo F. Garibaldi - Fisica e tecnologie Nucleari per la Salute.
Medical Imaging and Anatomy Mike Houston, Anthony Sherbondy, Ruwen Hess.
Chapter 8 Planar Scintigaraphy
Nuclear Medicine. Nuclear Medicine Physiological Imaging Radioactive isotopes which emit gamma rays or other ionizing forms (half life for most is hours.
Buxton & District Science Discussion Medical Scanners Marge Rose 16 th November 2012.
16 November 2004Biomedical Imaging BMEN Biomedical Imaging of the Future Alvin T. Yeh Department of Biomedical Engineering Texas A&M University.
In biochemical recurrence after curative treatment of prostate cancer, Choline PET/CT 1- has a detection rate of 10-20% when PSA: 1-2 ng/ml 2- has a detection.
Current Topics in Medical Physics Research Xiaoming Zheng, PhD. School of Dentistry and Health Science Chengdu, China, 2009.
Nuclear Medicine Spring 2009 FINAL. 2 NM Team Nuclear medicine MD Nuclear medicine MD Physicist Physicist Pharmacist Pharmacist Technologist Technologist.
Medical Imaging Mohammad Dawood Department of Computer Science University of Münster Germany.
Medical Imaging Mohammad Dawood Department of Computer Science University of Münster Germany.
Gamma Camera Technology
Topics in Medical Physics Xiaoming Zheng, PhD. School of Dentistry and Health Sciences December 2009, Chengdu.
Compton Identification Within Single ‘Pixels’ D. Scraggs, A. Boston, H. Boston, R. Cooper, J. Cresswell, A. Grint, A. Mather, P. Nolan University of Liverpool.
PHYSICS IN NUCLEAR MEDICINE: QUANTITAITVE SPECT AND CLINICAL APPLICATIONS Kathy Willowson Department of Nuclear Medicine, Royal North Shore Hospital University.
Single Photon Computerized Tomography SPECT neuroimaging Seyed Kazem Malakouti, MD Faculty of Iran University of Medical Sciences Seyed Kazem Malakouti,
Planar scintigraphy produces two-dimensional images of three dimensional objects. It is handicapped by the superposition of active and nonactive layers.
An Introduction to Molecular Imaging in Radiation Oncology : A report by the AAPM Working Group on Molecular Imaging in Radiation Oncology(WGMIR) Tuesday.
The content of these slides by John Galeotti, © Carnegie Mellon University (CMU), was made possible in part by NIH NLM contract# HHSN P,
Positron Emission Tomography
8/18/2015G.A. Fornaro Characterization of diffractive optical elements for improving the performance of an endoscopic TOF- PET detector head Student: G.
Introduction to Nuclear Medicine
There are currently 26 million people worldwide with Alzheimer’s disease. This figure is projected to grow to more than 106 million people by 2050.
Very High Resolution Small Animal PET Don J. Burdette Department of Physics.
Nuclear Medicine. The History Henri Becquerel 1896-Discovered mysterious “rays” Nobel Prize Marie Curie named mysterious rays “radioactivity”
F. Garibaldi – INFN Roma and ISS
High Resolution and High Efficiency Open SPECT Detector for Molecular Imaging Studies of Cardiovascular Diseases on Mice MIOCARDIAL PERFUSION MEASUREMENTS.
Characterization of LaBr3:Ce scintillator optimized for spatial resolution in low-energy gamma detection F. Cusanno, E. Cisbani, S. Colilli, R. Fratoni,
NA-MIC National Alliance for Medical Image Computing Mechanically Assisted Trans- Rectal Prostate Biopsy DBP2: Prostate Interventions,
F. Garibaldi 1,, for TOPEM collaboration TOPEM: a PET TOF endorectal probe, compatible with MRI for diagnosis and follow up of prostate cancer endorectal.
Fundamental Limits of Positron Emission Tomography
Medical Image Analysis Dr. Mohammad Dawood Department of Computer Science University of Münster Germany.
Interaction ionizing radiation with biological tissue. Basic dosimetry.
Md.Kausher ahmed Electrical department. Biomedical engineering Code:6875.
HEALTH Novel MR-compatible PET detectors for simultaneous PET/MRI imaging FP7-HEALTH-2009-single-stage The focus should be to develop novel.
Nuclear Medicine: Planar Imaging and the Gamma Camera Katrina Cockburn Nuclear Medicine Physicist.
BMI I FS05 – Class 4 “Nuclear Imaging: Math” Slide 1 Biomedical Imaging I Class 5 – Radionuclide Imaging (PET, SPECT), Part 3: Attenuation and Scatter.
Professor Brian F Hutton Institute of Nuclear Medicine University College London Emission Tomography Principles and Reconstruction.
Ultrasound, Positron Emission Tomography, and Single Photon Emission Tomography Allen T. Newton, Ph.D. PAVE 2014.
Li HAN and Neal H. Clinthorne University of Michigan, Ann Arbor, MI, USA Performance comparison and system modeling of a Compton medical imaging system.
Nuclear Medicine: Tomographic Imaging – SPECT, SPECT-CT and PET-CT Katrina Cockburn Nuclear Medicine Physicist.
Nuclear Medicine Principles & Technology_I
Molecular Imaging & Positron Emission Tomography Nicholas Mulhern BME 281.
Rebecca Barrett CRYSTAL LAB. PET Detects gamma rays Interact with the crystals and release photons Smaller the crystal, the less uncertainty.
Medical applications of particle physics General characteristics of detectors (5 th Chapter) ASLI YILDIRIM.
Advanced Biomedical Imaging Dr. Azza Helal A. Prof. of Medical Physics Faculty of Medicine Alexandria University.
Prostate probe with SPECT technique NSS – MIC November 5 - KnoxvilleF. Garibaldi- INFN – Roma1 – gr. Coll. ISS  the medical problem  the proposal.
Timing in Thick Silicon Detectors Andrej Studen, University of Michigan, CIMA collaboration.
Nuclear Medicine Technique I 355 RAD L.Aya Ahmed Saeed.
CAT scanners and gamma cameras Unit 16 Waves. Learning objectives Describe how CAT scanners can produce a much more detailed image than conventional X-rays.
F. Garibaldi 1,, F. Cusanno 1), S. Majewski 3), N. Clinthorne, P. Musico 4),…………………………. TOPEM: a PET TOF probe, compatible with MRI and MRS for diagnosis.
Nuclear Medicine Physics and Equipment 243 RAD 1 Dr. Abdo Mansour Assistant Professor of radiology
Nuclear Medicine Instrumentation 242 NMT 1 Dr. Abdo Mansour Assistant Professor of radiology
 Two reasons medical tracers can be placed in a body:  Diagnose disease or Treat Disease  In both cases, several factors must be accounted for:  Gamma.
Prostate probe with SPECT technique NSS – MIC November 5 - KnoxvilleF. Garibaldi- INFN – Roma1 – gr. Coll. ISS  the medical problem  the proposal.
Muhammad Musaddiq.
Gamma Camera Technology
Nuclear imaging for prostate cancer: What’s new?
P.E.T. Positron Emission Tomography
Imaging molecolare ad alta risoluzione spaziale ed alta efficienza
Quantitative Nuclear Medicine Imaging
Image quality and Performance Characteristics
F. Garibaldi1,, for TOPEM collaboration
Application of Nuclear Physics
Positron Emission tomography
F. Garibaldi1,, for TOPEM collaboration
First demonstration of portable Compton camera to visualize 223-Ra concentration for radionuclide therapy Kazuya Fujieda (Waseda University) J. Kataoka,
Assist. Prof. Dr. Ilker Ozsahin Oct
Presentation transcript:

Prostate probe with SPECT technique Workshop on endoscospic Imaging – Marseille – 13-01-2011 – F. Garibaldi ISS and INFN Roma1 the medical problem the proposal Compton option Collimation techniques SiPM/electronics Multimodality summary and outlook

Stem cell workshop – Marseille - December 2008 Compton Camera Applications to Bio-medical Imaging (Mattinata 5-7 September 2002) Stem cell workshop – Marseille - December 2008 Topical Symposium on Advanced molecular intraoperative probes assisting surgical interventions TOF PET workshop Baia delle Zagare September 2009 next ?

Global incidence of prostate cancer* - etherogenous, multifocal, biologically not well understood The most common cancer in men, in western countries (97% of all cancers in men) (EJNM (2008),35:1019-1025) Global incidence of prostate cancer* the second leading cause of cancer death <7.4 7.4-13.8 13.8-24.5 24.5-40.7 40.7-124.8 There are considerable geographical variations in the incidence of prostate cancer, and environmental factors, such as diet and lifestyle, are recognised as contributors to the development of the disease. Prostate cancer is the most commun malignancy in men and one of the leading causes of cancer death - Primary or recurrent cancer confined in the organ can be curatively treated Thus it is important, at primary diagnosis, follow up and recurrence, to obtain accurate assessment of the diesease stage in order to decide the most effective treatment strategy (EJNM (2008),35:1019-1025) *Age-standardised incidence rates per 100,000 GLOBOCAN 2002

SENSITIVITY 83% SPECIFICITY 17% PSA prostate specific, not cancer specific (prostatitis, prostatic iperplasia, prostate cancer) SENSITIVITY 83% SPECIFICITY 17% PSA Selective indication : PSA > 10 ng/ml cT3 Gleason score > 7 CT Unfortunately PSA is uneuseful in the so called “gray zone” where 25% of the patients fall down diagnosis is made from tissue obtained in a blind biopsy Need to consider fundamental changes in the approach to diagnosing prostate cancer In the future, multimodality imaging approach tailored to each patient PSADRETRUS biopsy

Radionuclides imaging techniques Patient injected with radioactive drug. Drug localizes according to its metabolic properties. Gamma rays, emitted by radioactive decay, that exit the patient are imaged. Collimator Only gammas that are perpendicular to imaging plane reach the detector Readout Electronics Amplify electrical signal and interface to computer Scintillator Converts gammas to visible light Computer decoding procedure Elaborate signal and gives image output Photodetector Convert light to electrical signal

mechanical collimation Compton Camera mechanical collimation PET Multi pinhole

Single photon techniques pros simple(r) cheape(r) extending the radiotracers available dual tracer  looking at two different biological processes cons - efficiency spatial resolution

Compton Prostate Imaging Probe Internal Compton Probe External Compton Probe

Conventional SPECT Reconstructions 5:1 10:1 15:1 20:1 w / tumor Prostate bkgd 171 and 245 keV, 8.8M events / 40 slices Spatial resolution ~15mm FWHM

Compton Prostate Probe Reconstructions 245 keV only, 1.2 million events, 8mm lesion Prostate 5:1 10:1 15:1 20:1 w / tumor bkgd Spatial resolution ~2mm FWHM

Internal Detector Details 10–12 layers of 1mm thick Si detectors + position and orientation sensor Exploded View Assembled Unit

Detector Packaging Use Tape Automated Bonding (TAB) (Very thin kapton tape with aluminum traces) Kapton microcables “Raw” energy spectrum Detector VATA ASIC Unfolded energy spectrum Kapton “hybrid” board

Demise of the Compton Prostate Probe Decreasing interest in imaging single photon agents “Coincidence” PET cameras not reimbursed by HCFA Technology ultimately was a bit far off

Single photon Compton camera ( N. Clinthorne. Michigan )

Radionuclides Single photon 111In-ProstaScint is not a good radiotracer but a new one proposed by M. Pomper looks promising. The single photon endorectal probe provides 2D imaging. We have to try to have 3 D images ( using multipinhole collimation and/or adding up a SPECT tomograph (spatial resolution would be dominated by the small probe (see later, the PET case))

-insert scintillator pixels into square holes of the collimator our proposal -insert scintillator pixels into square holes of the collimator  better performances (spatial resolution (?) and sensitivity (thicker scintillator)) -using diverging collimator  better performances (reducing scan time) -using multipinhole collimation  better performances (increasing sensitivity, tomographic recinstruction)

CANCER LOCALIZATION TRANSIZION ZONE CENTRAL ZONE PERIPHERAL ZONE Around to prostatic urethra 25% prostatic parenchyma 20% prostate cancer CENTRAL ZONE Encircles the Eyaculatory ducts 10% prostatic parenchyma 1-5% Prostate cancer One of the big problem is multifocality of the prostate cancer, who make the diagnosis difficult. It can be like the pinpointed skin of the leopard PERIPHERAL ZONE Region postero-lateral 70% prostatic parenchyma ≥ 70% prostate cancer CANCER LOCALIZATION

Radiotracers available for SPECT and PET Radiotracers issue Radiotracers available for SPECT and PET (from “New agents and Techniques for Imaging prostate cancer” A. Zahreer, S. Y. Cho, M. Pomper”, to be published on JNM) SPECT: Prostascint, Bombesyn, 99mTechnetium nanocolloid (limphonodes), other coming soon… PET C—11 Choline, F-18-Choline, Ga-68 Dotabomb (Hofmann (Rome workshop)) many others coming… (collaboration with Johns Hopkins for testing in ISS (mice models for prostate available) and/or at JHU)

PET MRI advantages and issues and fMRI ? - CITRATE that is present in the normal prostate CREATINA that may increase in the phlogosis and all the proliferative processes - COLINE specific for a neoplastic transformation “In conclusion, our results confirm that simultaneous PET and high-field-strength MR imaging with LSO-APD–based PET detectors is feasible without sacrificing the quality of images obtained with either system.” M.S. Judenhofer et al. Nature Medicine, Vol. 14 N 4, pg. 439, April 2008

??

Summary and Conclusions - prostate cancer detection, diagnosis and staging very difficult standard imaging systems suffer from VERY low specificity - better radiotracers + multimodality can be the solution single photon techniques are an option because simpler and cheaper than PET dual tracer multimodality with MRI possible FDA approved for tests on humans better radiotarcers coming soon - Using also an external SPECT? - Prospectives: Compton